Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Precision Medicine in Targeting ROS1- Rearranged Non-small Cell Lung Cancer


Yasar Ahmed, Dennehy C, Jordan E and Calvert P

Globally, lung cancer is the leading cause of death from cancer among men and women. The overall 5-year survival rate of lung cancer is around 16-19%. The emergence of targeted therapy and immunotherapy have changed the treatment paradigm of advanced NSCLC.


Share this article

Google Scholar citation report
Citations: 3968

Cancer Science & Therapy received 3968 citations as per Google Scholar report

Cancer Science & Therapy peer review process verified at publons

Indexed In

arrow_upward arrow_upward